Papillary thyroid microcarcinoma: Prognostic factors and treatment

Journal of Surgical Oncology

Volumn 97, Issue 3, 2008, Pages 221-225

  Besic, Nikola ^a   Pilko, Gasper ^a   Petric, Rok ^a   Hocevar, Marko ^a   Zgajnar, Janez ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Outcome; Papillary thyroid carcinoma; Prognosis; Prognostic factors; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; DISEASE FREE INTERVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; SUBTOTAL THYROIDECTOMY; THYROID PAPILLARY CARCINOMA;

EID: 39749159917     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20935     Document Type: Article

References (28)

1. 1 Schlumberger MJ: Papillary and follicular thyroid carcinoma. N Engl J Med 1998 ; 338: 297–306.
2. 2 Pompe‐Kirn V: Podrobnejši pregled trenda incidence raka ščitnice v obdobju1983–2002 v Sloveniji. Onkologija 2005 ; 1: 12–14.
3. 3 Mazzaferri EL, Jhiang SM: Long‐term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994 ; 97: 418–428.
4. 4 Hedinger CW, Sobin LH: Histologic typing of thyroid tumours. In: Hedinger CW, Sobin LH, editors. International histological classification of tumours No. 11. Geneva: World Health Organization 1988 ; pp. 1–18.
5. 5 Gomez Segovia I, Gallowitsch HJ, Kresnik E, et al.: Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984–2001.Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: Population‐based age‐stratified analysis on thyroid carcinoma incidence. Thyroid 2004 ; 14: 277–286.
6. 6 Appetecchia M, Scarcello G, Pucci E, et al.: Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res 2002 ; 21: 159–164.
7. 7 Pelizzo MR, Boschin IM, Toniato A, et al.: Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol 2006 ; 32: 1144–1148.
8. 8 Bramley MD, Harrison BJ: Papillary microcarcinoma of the thyroid gland. Br J Surg 1996 ; 83: 1674–1683.
9. 9 Roti E, Rossi R, Trasforini G, et al.: Clinical and histological characteristics of papillary thyroid microcarcinoma: Results of a retrospective study in 243 patients. J Clin Endocrinol Metab 2006 ; 91: 2171–2178.
10. 10 Cheema Y, Olson S, Elson D, et al.: What is the biology and optimal treatment for papillary microcarcinoma of the thyroid? J Surg Res 2006 ; 134: 160–162.
11. 11 Hay ID, Bergstralh EJ, Goellner JR, et al.: Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993 ; 114: 1050–1057 ; discussion 1057–1058.
12. 12 Cady B, Rossi R: An expanded view of risk‐group definition in differentiated thyroid carcinoma. Surgery 1988 ; 104: 947–953.
13. 13 Pellegriti G, Scollo C, Lumera G, et al.: Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: Study of 299 cases. J Clin Endocrinol Metab 2004 ; 89: 3713–3720.
14. 14 Hay ID, Grant CS, van Heerden JA, et al.: Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50‐year period. Surgery 1992 ; 112: 1139–1146 ; discussion 1146–1137.
15. 15 Baudin E, Travagli JP, Ropers J, et al.: Microcarcinoma of the thyroid gland: The Gustave‐Roussy Institute experience. Cancer 1998 ; 83: 553–559.
16. 16 Sobin LH, Wittekind WC: Thyroid gland. In Sobin LH, Wittekind WC (eds.). TNM classification of malignant tumours. New York: Wiley‐Liss. 2002 ; pp. 52–56.
17. 17 Kaplan EL, Meier MP: Non‐parametric estimation from incomplete observations. J Am Stat Assoc 1958 ; 53: 457–481.
18. 18 Passler C, Scheuba C, Prager G, et al.: Prognostic factors of papillary and follicular thyroid cancer: Differences in an iodine‐replete endemic goiter region. Endocr Relat Cancer 2004 ; 11: 131–139.
19. 19 Sugitani I, Fujimoto Y: Symptomatic versus asymptomatic papillary thyroid microcarcinoma: A retrospective analysis of surgical outcome and prognostic factors. Endocr J 1999 ; 46: 209–216.
20. 20 Ito Y, Tomoda C, Uruno T, et al.: Papillary microcarcinoma of the thyroid: How should it be treated? World J Surg 2004 ; 28: 1115–1121.
21. 21 Lo CY, Chan WF, Lang BH, et al.: Papillary microcarcinoma: Is there any difference between clinically overt and occult tumors? World J Surg 2006 ; 30: 759–766.
22. 22 Kebebew E, Peng M, Reiff E, et al.: Diagnostic and prognostic value of angiogenesis‐modulating genes in malignant thyroid neoplasms. Surgery 2005 ; 138: 1102–1109 ; discussion 1109–1110.
23. 23 Rassael H, Thompson LD, Heffess CS: A rationale for conservative management of microscopic papillary carcinoma of the thyroid gland: A clinicopathologic correlation of 90 cases. Eur Arch Otorhinolaryngol 1998 ; 255: 462–467.
24. 24 DeGroot LJ, Kaplan EL, McCormick M, et al.: Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990 ; 71: 414–424.
25. 25 Cappelli C, Castellano M, Braga M, et al.: Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): A mono‐institutional experience. J Surg Oncol 2007 ; 95: 555–560.
26. 26 Ito Y, Tomoda C, Uruno T, et al.: Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 2006 ; 30: 91–99.
27. 27 Chow SM, Law SC, Mendenhall WM, et al.: Papillary thyroid carcinoma: Prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys 2002 ; 52: 784–795.
28. 28 Cooper DS, Doherty GM, Haugen BR, et al.: Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006 ; 16: 109–142.